Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs
Journal Title: AAPS PharmSciTech - Year 2014, Vol 15, Issue 3
Abstract
It has been advocated that biopharmaceutic risk assessment should be conducted early in pediatric product development and synchronized with the adult product development program. However, we are unaware of efforts to classify drugs into a Biopharmaceutics Classification System (BCS) framework for pediatric patients. The objective was to classify five drugs into a potential BCS. These five drugs were selected since both oral and intravenous pharmacokinetic data were available for each drug, and covered the four BCS classes in adults. Literature searches for each drug were conducted using Medline and applied to classify drugs with respect to solubility and permeability in pediatric subpopulations. Four pediatric subpopulations were considered: neonates, infants, children, and adolescents. Regarding solubility, dose numbers were calculated using a volume for each subpopulation based on body surface area (BSA) relative to 250 ml for a 1.73 m2 adult. Dose numbers spanned a range of values, depending upon the pediatric dose formula and subpopulation. Regarding permeability, pharmacokinetic literature data required assumptions and decisions about data collection. Using a devised pediatric BCS framework, there was agreement in adult and pediatric BCS class for two drugs, azithromycin (class 3) and ciprofloxacin (class 4). There was discordance for the three drugs that have high adult permeability since all pediatric permeabilities were low: dolasetron (class 3 in pediatric), ketoprofen (class 4 in pediatric), and voriconazole (class 4 in pediatric). A main contribution of this work is the identification of critical factors required for a pediatric BCS.
Authors and Affiliations
Shivani V. Gandhi, William Rodriguez, Mansoor Khan, James E. Polli
Keywords
Related Articles
- EP ID EP682384
- DOI 10.1208/s12249-014-0084-0
- Views 108
- Downloads 0
Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System
The objective of this study was to improve the solubility and bioavailability of curcumin by a new curcumin dripping pills (Cur-DPs) formulation using melt mixing methods. The optimal formulation consisted of Polyethoxyl...
The Influence of Ionizing Radiation on Itraconazole in the Solid State
The aim of this study was to investigate the ionizing radiation effects, in the form of an electron beam, on itraconazole (ITR) in the solid phase. It was found that the ITR, under the influence of a standard 25 ...
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review
Thermal processing of amorphous solid dispersions continues to gain interest in the pharmaceutical industry, as evident by several recently approved commercial products. Still, a number of pharmaceutical polymer carriers...
A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME
The online version of this article (doi:10.1208/s12249-015-0395-9) contains supplementary material, which is available to authorized users.
Novel Self-assembly Endows Human Serum Albumin Nanoparticles with an Enhanced Antitumor Efficacy
The online version of this article (doi:10.1208/s12249-013-0041-3) contains supplementary material, which is available to authorized users.